NPCE
#2815
Neuropace, Inc. - Common Stock
17.1 2 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.06%
Monthly Change
+7.67%
6 month change
+2.21%
Year Change
+61.81%
Previous Close
17.1 1
Open
17.1 2
Low
17.1 2
High
17.1 2
Volume
35
Financials
- Market Capitalization 583.68 M
- Employee 220
- Founded 1997
- CEO N/A
- Website www.neuropace.com
- Headquarter Delaware, United States
- FIGI BBG001KWZD52
- Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-23.39
Price to sales ratio
5.05
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2742 |  TCMD Tactile Systems Technology, Inc. - Common Stock | 29.04 USD | -2.65% | -10.23% | +9.50% | +188.96% | 655.03 M USD | ||
| 2775 |  CERS Cerus Corporation - Common Stock | 3.09 USD | -0.96% | -6.65% | +19.31% | +110.20% | 619.14 M USD | ||
| 2819 |  CTKB Cytek Biosciences, Inc. - Common Stock | 4.51 USD | -2.38% | -3.63% | +11.63% | +34.23% | 582.43 M USD | ||
| 2856 |  BWAY BrainsWay Ltd - American Depositary Shares | 14.10 USD | -6.37% | -9.90% | -2.76% | +14.82% | 552.24 M USD |
Frequently asked questions about Neuropace, Inc. - Common Stock
What is the Neuropace, Inc. - Common Stock stock price today?
The current price of Neuropace, Inc. - Common Stock (NPCE) is 17.12. Over the past 24 hours, the stock has changed by +0.06%. Follow the NPCE chart for real-time price dynamics.
What is the stock ticker of Neuropace, Inc. - Common Stock?
Neuropace, Inc. - Common Stock trades under the ticker NPCE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Neuropace, Inc. - Common Stock stock going up?
NPCE has changed by -1.33% over the last week, +7.67% over the last month, and +61.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Neuropace, Inc. - Common Stock net income for the last quarter?
Neuropace, Inc. - Common Stock reported net income of -6.69 M for the last quarter. The previous quarter showed -2.73 M, which means net income changed by -145.11%.
How many employees does Neuropace, Inc. - Common Stock have?
As of the latest available data, Neuropace, Inc. - Common Stock has 220 employees. Workforce size can provide additional context about the company's scale and operations.
What is Neuropace, Inc. - Common Stock EBITDA?
Neuropace, Inc. - Common Stock EBITDA is -5.44 M, and its EBITDA margin is -24.65%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Neuropace, Inc. - Common Stock stock?
You can buy Neuropace, Inc. - Common Stock (NPCE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Neuropace, Inc. - Common Stock stock?
Investing in Neuropace, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NPCE chart and related analysis on metatrader.com as part of your research.